These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Low-molecular-weight heparin for prevention of restenosis after femoropopliteal percutaneous transluminal angioplasty: a randomized controlled trial. Koppensteiner R; Spring S; Amann-Vesti BR; Meier T; Pfammatter T; Rousson V; Banyai M; van der Loo B J Vasc Surg; 2006 Dec; 44(6):1247-53. PubMed ID: 17145426 [TBL] [Abstract][Full Text] [Related]
11. Endovascular brachytherapy for the prevention of restenosis after femoropopliteal angioplasty. Results of the VARA Trial. van Tongeren RB; van Sambeek MR; van Overhagen H; Coen VL; Schmitz PI; Gescher FM; Wittens CH; Vernhout RM; van Urk H; Levendag PC; Bruijninckx CM J Cardiovasc Surg (Torino); 2005 Aug; 46(4):437-43. PubMed ID: 16160691 [TBL] [Abstract][Full Text] [Related]
12. Endovascular brachytherapy: restenosis in de novo versus recurrent lesions of femoropopliteal artery--the Vienna experience. Wolfram RM; Budinsky AC; Pokrajac B; Potter R; Minar E Radiology; 2005 Jul; 236(1):338-42. PubMed ID: 15955854 [TBL] [Abstract][Full Text] [Related]
13. Possible impact of iridium-192 source centering on restenosis rate after femoro-popliteal angioplasty and endovascular brachytherapy in Vienna-2 study. Pokrajac B; Schmid R; Kirisits C; Mock U; Fellner C; Wambersie A; Pötter R; Minar E Radiother Oncol; 2002 Apr; 63(1):97-102. PubMed ID: 12065109 [TBL] [Abstract][Full Text] [Related]
14. Endovascular brachytherapy in the prevention of vascular restenosis. Dvorák J; Fridrich J; Raupach J; Petera J; Krajina A; Lojík M; Masková J; Vodnanský P; Zoul Z; Odrázka K; Kalousová D; Chovanec V Cardiovasc Radiat Med; 2001; 2(3):130-2. PubMed ID: 11786317 [TBL] [Abstract][Full Text] [Related]
15. 192IR endovascular brachytherapy for avoidance of intimal hyperplasia after percutaneous transluminal angioplasty and stent implantation in peripheral vessels: 6 years of experience. Schopohl B; Leirmann D; Pohlit LJ; Heyd R; Strassmann G; Bauersachs R; Schulte-Huermann D; Rahl CG; Manegold KH; Kollath J; Bottcher HD Int J Radiat Oncol Biol Phys; 1996 Nov; 36(4):835-40. PubMed ID: 8960510 [TBL] [Abstract][Full Text] [Related]
16. Drug-Eluting Stent vs Percutaneous Transluminal Angioplasty for Treatment of Femoropopliteal In-Stent Restenosis: Results From a Retrospective 1-Year Multicenter Study. Murata N; Takahara M; Soga Y; Nakano M; Yamauchi Y; Zen K; Kawasaki D; Yokoi H; Tosaka A; Tanaka N; Iida O J Endovasc Ther; 2016 Aug; 23(4):642-7. PubMed ID: 27099284 [TBL] [Abstract][Full Text] [Related]